SUBSCRIBE
SUBSCRIBE

Food and Drug Administration (FDA)

NEWS
Policy
FDA Process Hampers Medical Devices Innovation, Study Says
May 26, 2011
 · 
1 min read
Policy
Medical Device Interfaces are Subject to FDA Rules, Says IT Expert
May 25, 2011
 · 
1 min read
Policy
FDA Process Pushes Innovative Medical Devices Abroad, Survey Shows
May 25, 2011
 · 
1 min read
BioCapital
The Murky World of FDA Data
May 23, 2011
 · 
1 min read
Policy
Lack of FDA Guidance Delays Device Firms’ Adoption of Social Media
May 17, 2011
 · 
1 min read
Policy
FDA Mulling Higher User Fees For Bundled Device Submissions
May 17, 2011
 · 
1 min read
Policy
Metal Hip Replacements: Toxic Effects? - FDA Asks
May 16, 2011
 · 
1 min read
Policy
Medical Devices - Risk Of Acquiring Infection From Reprocessed Medical Devices, FDA Discusses
May 12, 2011
 · 
1 min read
Policy
New Drugs Often Marketed FDA Ahead of Crucial Data
May 6, 2011
 · 
1 min read
Load More
JOBS
IN THE PRESS
Press Releases
Praxis Precision Medicines Announces Extension Period for Relutrigine for Treatment of SCN2A and SCN8A Developmental and Epileptic Encephalopathies
June 30, 2026
 · 
3 min read
Press Releases
DBV Technologies Provides BLA Submission Update for the VIASKIN® Peanut Patch in Children Aged 4 through 7 Years; Working Collaboratively with FDA to Optimize Review Process in Preparation for Filing
June 30, 2026
 · 
5 min read
Press Releases
Gain Therapeutics Receives FDA Clearance of IND to Advance GT-02287 into Phase 2 Clinical Development for Parkinson’s Disease
June 30, 2026
 · 
8 min read
Press Releases
Palisade Bio Receives FDA Clearance of IND for PALI-2108 and Plans to Initiate Global Phase 2 ASCENTRA-UC Study in Ulcerative Colitis
June 29, 2026
 · 
6 min read
Press Releases
Satellos Receives FDA Fast Track Designation for SAT-3247 for the Treatment of Duchenne Muscular Dystrophy
June 29, 2026
 · 
7 min read
Press Releases
Tonix Pharmaceuticals Announces First Patient Enrolled in Phase 2 HORIZON Study of TNX-102 SL for the Treatment of Major Depressive Disorder (MDD)
June 29, 2026
 · 
14 min read
Press Releases
Larimar Therapeutics Reports Positive Open Label Data and Submission of First Module of Rolling BLA for Accelerated Approval of Nomlabofusp for Friedreich’s Ataxia
June 29, 2026
 · 
14 min read
Press Releases
SKYRIZI® (risankizumab-rzaa) Now FDA Approved for Pediatric Use in Psoriatic Disease
June 28, 2026
 · 
13 min read
Press Releases
Anivive Lifesciences Announces FDA Approval of Laverdia®, the First Oral Treatment of Its Kind for Canine Lymphoma
June 28, 2026
 · 
4 min read
Press Releases
Capricor Therapeutics Announces FDA Advisory Committee Meeting to Review BLA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy
June 28, 2026
 · 
6 min read
Load More